Last week, a woman was struck and killed by a New Jersey Transit train that was heading south towards Long Branch. The accident occurred just east of the Hazlet train station. Authorities said the woman was trespassing on the tracks at the time of the incident. The official cause of death is still undetermined, and an investigation into the accident is still in progress. The train was slowing down to stop at the Hazlet station when it struck the woman. A spokesman for NJ Transit stated that he did not know the exact speed the train was moving at when it struck the woman.
New Jersey Woman Killed After Being Hit by Commuter Train
Manhattan Carriage Horse Accident Injures 3
Horse-drawn carriages are a relatively common sight throughout New York City, especially near Central Park. However, while riding in a carriage may be a fun diversion, it is not always safe.
Protest Planned After Student Killed by NJ Transit Bus
Last month, a New Jersey college student was killed after being run over by a NJ Transit bus in Bloomfield Township. Now, his family and friends are planning a protest on the one-month anniversary of the young man's death. They claim that the transit accident was caused by the bus driver's negligence and say that neither the government nor NJ Transit are doing enough to address the situation.
Traumatic Brain Injury Linked to Increased Alzheimer's Risk
Traumatic brain injuries are some of the most devastating consequences of a motor vehicle accident. TBIs can lead to debilitating symptoms such as severe headaches, cognitive problems and even personality changes. In addition, a new study published in the Journal of Neuroscience shows that a single TBI can greatly increase a person's risk of developing Alzheimer's disease.The study, which was performed using rodents and post-mortem samples from Alzheimer's disease patients, discovered that even a single TBI can reduce the availability of particular proteins that have been known to combat an enzyme linked to Alzheimer's. The results of this study could lead to the development of drugs that can zero in on this mechanism, and ultimately slow down the advancement of Alzheimer's disease.
